Consytel Life Sciences

Hyderabad, India Founded: 2017 • Age: 9 yrs
Nature-derived malaria products are manufactured for immune health support.

About Consytel Life Sciences

Consytel Life Sciences is a Healthcare company based in Hyderabad (India) founded in 2017 by Shubhendu Kumar Dash. It operates as a nature-derived malaria products are manufactured for immune health support. Consytel Life Sciences has raised $44.28 thousand across 1 funding round from investors including AIC-CCMB. Its Indian entity Consytel Life Sciences Private Limited reported revenue of β‚Ή39 Lakh. Its focus areas include Alternative Medicine Products.

Company details

Consytel Life Sciences was founded in 2017 and is based in Hyderabad, India. Operations focus on the life sciences sector, where nature-derived products for malaria treatment are produced. Emphasis is placed on supporting immune system function for overall human health maintenance. Manufacturing processes are centered on natural ingredients, with activities conducted primarily in the Indian pharmaceutical landscape.

  • Headquarters Hyderabad, India
  • Founders Shubhendu Kumar Dash
  • Sectors
    Healthcare
  • Email
    β€’β€’β€’β€’β€’β€’β€’β€’
  • Phone
    β€’β€’β€’β€’ β€’β€’β€’β€’
  • Website consytel.com
  • Social LinkedIn
  • Legal Name Consytel Life Sciences Private Limited
  • Date of Incorporation 22 Dec, 2017
  • Jurisdiction Secunderabad, Telangana, India
Key Metrics
  • Annual Revenue
    ₹39 Lakh

    FY 2024 · +11% YoY

  • Net Profit
    ₹1.1 Lakh

    FY 2024 · 3% margin

  • EBITDA
    ₹2.4 Lakh

    FY 2024 · 6% margin

  • Total Equity Funding
    $44.28K (USD)

    in 1 rounds

  • Latest Funding Round
    $44.28K (USD), Seed

    Jan 2026

  • Investors

Funding Insights of Consytel Life Sciences

Consytel Life Sciences has successfully raised a total of $44.28K through 1 strategic funding round. The most recent funding activity was a Seed round of $44.28 thousand completed in January 2026. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.

  • Total Funding $44,282
  • Total Rounds 1
  • Last Round Seed β€” $44,282
  • First Round $44,282

    (Jan 2026)

  • Investors Count 1

All 1 funding rounds of Consytel Life Sciences with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.

DateAmountTransaction NameValuationLead InvestorsInvestors
Jan 2026$44,282Seed–AIC-CCMB
–
Valuation history

1 investors in total: 1 institutional.

Investors in Consytel Life Sciences

Consytel Life Sciences has secured backing from 1 investor, including venture fund investors. Prominent investors backing the company include AIC-CCMB.

All
Venture Fund
InvestorDescriptionFounded YearDomainLocation
-
–aic.ccmb.res.in-
Premium access

Investor details for Consytel Life Sciences

The complete investor list, round-by-round participation and investor portfolios require an active premium plan.

  • Complete investor list
  • Round participation
  • Investor portfolios
  • Co-investor network

Verified entity values are shown only after access is granted.

Board of directors of Consytel Life Sciences Private Limited (Consytel Life Sciences)

Consytel Life Sciences Private Limited is the primary company behind Consytel Life Sciences. The board of Consytel Life Sciences Private Limited currently have 4 directors; the longest-serving is Sandhyarani Dash, appointed in 2017.

DirectorDesignationAppointedTenureEntity
Sandhyarani Dash
DIN 08001272
Director22 Dec 20178 yrs 9 moConsytel Life Sciences Private Limited
Shubhendu Kumar Dash
DIN 05222282
Director22 Dec 20178 yrs 9 moConsytel Life Sciences Private Limited
Swagatika Satpathy
DIN 08563800
Director01 Nov 20196 yrs 11 moConsytel Life Sciences Private Limited
Saurabh Dash
DIN 09782133
Director04 Nov 20223 yrs 11 moConsytel Life Sciences Private Limited

People of Consytel Life Sciences

1 people are tracked at Consytel Life Sciences (1 in leadership).

NameRoleGroup
Founder & Managing DirectorLeadership
Premium access

Complete people profiles for Consytel Life Sciences

Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.

  • Full employee list
  • Team structure
  • Board tenure
  • Professional contacts

Verified entity values are shown only after access is granted.

Financials of Consytel Life Sciences

Figures of Consytel Life Sciences Private Limited, the primary company behind Consytel Life Sciences, for FY 2024. Revenue was ₹39 Lakh (+11% year on year). Net profit was ₹1.1 Lakh (3% margin). EBITDA was ₹2.4 Lakh (6% margin). Revenue has grown at a compounded annual rate of +13% over three years and +89% over five years.

  • ₹39 LakhRevenue · FY 2024 · +11% YoY
  • ₹1.1 LakhNet profit · 3% margin
  • ₹2.4 LakhEBITDA · 6% margin
  • ₹10.2 LakhPaid-up capital
  • +13%Revenue CAGR, 3 years
  • +89%Revenue CAGR, 5 years

Balance sheet, profit and loss, cash flow and ratios of Consytel Life Sciences Private Limited are on its company page.

Premium access

Detailed financial statements for Consytel Life Sciences

Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.

  • Statement rows
  • Financial ratios
  • Five-year trends
  • Downloads

Verified entity values are shown only after access is granted.

Timeline of Consytel Life Sciences

2 dated milestones of Consytel Life Sciences across 9 years, from founding to its latest funding, stage changes and deals.

  1. Founded Consytel Life Sciences is founded.
  2. Funding First funding round of $44K.

Top companies in Alternative Medicine Products

10 companies that operate in the same segment as Consytel Life Sciences (Alternative Medicine Products), ranked by their profile score on The Company Check.

CompanyDescriptionFoundedLocationTotal fundingRevenueEmployees
Homeopathic medicine manufacturing and online retail in India.
1898Noida, Uttar Pradesh, India–USD 26.35 M1,192
Operates an online store specializing in ayurvedic and homeopathic medicines.
2016Delhi, Delhi, India–USD 1.25 M16
Pharmaceutical therapies for smell and taste loss are developed.
2014Washington, District Of Columbia, United StatesUSD 25.88 M––
Offers Ayurvedic treatments, consultations, and products for various diseases and wellness.
1992Faridabad, Haryana, India–USD 10.08 M570
Ayurvedic company manufacturing natural soaps, body washes, and health products.
1969Chennai, Tamil Nadu, India–USD 51.17 M418
Chinese medicines are researched, developed, manufactured, and supplied.
2001Heze, Shandong, China–USD 1.68 B–
Herbal medicines and supplements for health categories are manufactured.
1933Neumarkt-sankt Veit, Bavaria, Germany–USD 510.09 M196
Provides Ayurvedic healing therapies, massages, and wellness services in India.
–Kochi, Kerala, India–USD 230.35 K42
Homeopathic medicines are supplied and distributed by Boiron worldwide.
1932Newtown Square, Pennsylvania, United States–––
Ayurvedic personal and sexual wellness products are manufactured and distributed.
2015Mumbai, Maharashtra, India–USD 15.13 M38
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track β€” from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • βœ“
    Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • βœ“
    Full access to every database India & global coverage, advanced filters and rich profile details
  • βœ“
    Always-on access from your team account Single premium plan for everything you see on the portal

Frequently Asked Questions about Consytel Life Sciences

Consytel Life Sciences was founded in 2017 and raised its 1st funding round 9 years after it was founded.

Consytel Life Sciences is headquartered in Hyderabad, India. It is registered at Hyderabad, Telangana, India.

Consytel Life Sciences is a funded company, having raised a total of $44.28K across 1 funding round to date. The company's 1st funding round was a Seed of $44.28K, raised on Jan 2026.

The primary company behind Consytel Life Sciences, Consytel Life Sciences Private Limited, reported revenue of β‚Ή39 Lakh for FY 2024, up 11% year on year.

Consytel Life Sciences was founded in 2017 and is based in Hyderabad, India. Operations focus on the life sciences sector, where nature-derived products for malaria treatment are produced. Emphasis is placed on supporting immune system function for overall human health maintenance. Manufacturing processes are centered on natural ingredients, with activities conducted primarily in the Indian pharmaceutical landscape.

Consytel Life Sciences has 1 investor. Key investors include AIC-CCMB.

Consytel Life Sciences operates through Consytel Life Sciences Private Limited.

The legal entities of Consytel Life Sciences currently have 4 directors, including Swagatika Satpathy, Saurabh Dash, Sandhyarani Dash and others.

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available